VADDI KRISHNA (President, CEO) purchased 3.1% of their position (39.10K shares) of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $29.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/18/2025ACC: 0001562180-25-002541
DirectorOfficer· President, CEO
Since Sep 2020
+39.10K
Net shares
Net buyer
$29.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
39.10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$0.75
Trade value
$22.63K
% of position
2.4%
3/14/2025
1.26M→1.29M
Common Stock
Direct
Shares
+9.11K
Price / share
$0.75
Trade value
$6.83K
% of position
0.7%
3/17/2025
1.29M→1.30M
Total
Net shares
+39.10K
Net value
$29.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2025 | P · Purchase | +30K | $0.75 | $22.63K | 2.4% | 1.26M | 1.29M |
| Common Stock Direct | 3/17/2025 | P · Purchase | +9.11K | $0.75 | $6.83K | 0.7% | 1.29M | 1.30M |
| Total | +39.10K | $29.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned423.65K
Common Stock
IndirectShares owned551.78K
Common Stock
IndirectShares owned142.55K
Common Stock
IndirectShares owned551.77K
Total
1.67M indirect1.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 423.65K | Indirect |
| Common Stock | 551.78K | Indirect |
| Common Stock | 142.55K | Indirect |
| Common Stock | 551.77K | Indirect |
| Total | 1.67M | 1.67M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported